(Q36634909)

15 August 2017

Hepatic clearance, but not gut availability, of erythromycin is altered in patients with end-stage renal disease (English)

1 reference

15 August 2017

1 reference

H Sun

1

1 reference

15 August 2017

L A Frassetto

series ordinal

2

1 reference

15 August 2017

Y Huang

series ordinal

3

1 reference

15 August 2017

L Z Benet

series ordinal

4

1 reference

15 August 2017

language of work or name

English

0 references

publication date

20 January 2010

1 reference

Clinical Pharmacology & Therapeutics

15 August 2017

1 reference

15 August 2017

87

1 reference

15 August 2017

4

1 reference

15 August 2017

465-472

1 reference

ESRD impairs nonrenal clearance of fexofenadine but not midazolam

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581054

Altered nonrenal drug clearance in ESRD.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581054

Emerging evidence of the impact of kidney disease on drug metabolism and transport

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581054

The erythromycin breath test reflects P-glycoprotein function independently of cytochrome P450 3A activity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581054

Effects of renal failure on drug transport and metabolism

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581054

Effects of uremic toxins on hepatic uptake and metabolism of erythromycin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581054

Sex differences in pharmacokinetics and pharmacodynamics

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581054

Hepatic drug metabolism and transport in patients with kidney disease.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581054

Sex is a major determinant of CYP3A4 expression in human liver

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581054

National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581054

The influence of sex on pharmacokinetics

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581054

The effect of chronic renal failure on hepatic drug metabolism and drug disposition

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581054

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581054

Identification of thyroid hormone transporters in humans: different molecules are involved in a tissue-specific manner

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581054

Age and gender related changes in stereoselective pharmacokinetics and pharmacodynamics of verapamil and norverapamil

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581054

Absorption and bioavailability of oral erythromycin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581054

The Effect of Renal Failure on Hepatic Drug Clearance

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581054

Pharmacokinetics and protein binding of eprosartan in healthy volunteers and in patients with varying degrees of renal impairment.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581054

Uptake is the rate-limiting step in the overall hepatic elimination of pravastatin at steady-state in rats.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581054

Changes in erythromycin pharmacokinetics induced by renal failure.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581054

Accumulation of furancarboxylic acids in uremic serum as inhibitors of drug binding

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581054

Extraction of protein bound ligands from azotemic sera: comparison of 12 deproteinization methods.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581054

Pharmacokinetics of intravenous erythromycin

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581054

Down-regulation of hepatic cytochrome p450 in chronic renal failure: role of uremic mediators

28 June 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.247

Pharmacokinetics and protein binding of eprosartan in hemodialysis-dependent patients with end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.247

Effect of protein-bound uraemic toxins on the thermodynamic characteristics of human albumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.247

Renal disposition of a furan dicarboxylic acid and other uremic toxins in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.247

In vivo modulation of intestinal CYP3A metabolism by P-glycoprotein: studies using the rat single-pass intestinal perfusion model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.247

CYP3A4-transfected Caco-2 cells as a tool for understanding biochemical absorption barriers: studies with sirolimus and midazolam

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.247

Effect of chronic renal failure on the expression and function of rat intestinal P-glycoprotein in drug excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.247

Down-regulation of intestinal drug transporters in chronic renal failure in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.247

Effects of chronic renal failure on liver drug transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.247

In vitro and in vivo correlation of hepatic transporter effects on erythromycin metabolism: characterizing the importance of transporter-enzyme interplay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.247

Downregulation of intestinal cytochrome p450 in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.247

Effects of uptake and efflux transporter inhibition on erythromycin breath test results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.247

Measurement of furancarboxylic acid, a candidate for uremic toxin, in human serum, hair, and sweat, and analysis of pharmacological actions in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.247

Do men and women differ in proximal small intestinal CYP3A or P-glycoprotein expression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.247

Direct measurement of chlormethiazole extraction by liver, lung and kidney in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.247

Sex is a major determinant of CYP3A4 expression in human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.247

Identification of Thyroid Hormone Transporters in Humans: Different Molecules Are Involved in a Tissue-Specific Manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.247

Gender-specific effects on verapamil pharmacokinetics and pharmacodynamics in humans

21 January 2018

1 reference

12 December 2020

Effect of chronic renal failure on the disposition of highly hepatically metabolized drugs

1 reference

12 December 2020

Decreased in vivo metabolism of drugs in chronic renal failure

1 reference

12 December 2020

Expression and function of P-glycoprotein in rats with glycerol-induced acute renal failure

1 reference

12 December 2020

A furan fatty acid and indoxyl sulfate are the putative inhibitors of thyroxine hepatocyte transport in uremia

1 reference

12 December 2020

Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis

1 reference

12 December 2020

Reduced renal clearance of furancarboxylic acid, a major albumin-bound organic acid, in undialyzed uremic patients

1 reference

12 December 2020

Effects of uremic toxins and fatty acids on serum protein binding of furosemide: possible mechanism of the binding defect in uremia

1 reference

12 December 2020

Liquid chromatographic tandem mass spectrometric assay for the uremic toxin 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid in human plasma

1 reference

12 December 2020

Hemodialysis acutely improves hepatic CYP3A4 metabolic activity

1 reference

12 December 2020

Role of parathyroid hormone in the downregulation of liver cytochrome P450 in chronic renal failure

1 reference

12 December 2020

Identifiers

DOI

10.1038/CLPT.2009.247

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

20090676

1 reference